Screener
Thermo Fisher Scientific TMO Europe — Consolidated revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 11:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000097745-26-000092
FAQ
- What is Thermo Fisher Scientific's europe — consolidated revenues?
- Thermo Fisher Scientific (TMO) reported europe — consolidated revenues of $2.96B in Q1 2026.
- How has Thermo Fisher Scientific's europe — consolidated revenues changed year-over-year?
- Thermo Fisher Scientific's europe — consolidated revenues increased by 12.7% year-over-year, from $2.62B to $2.96B.
- What is the long-term trend for Thermo Fisher Scientific's europe — consolidated revenues?
- Over 4 years (2021 to 2025), Thermo Fisher Scientific's europe — consolidated revenues has grown at a 1.5% compound annual growth rate (CAGR), from $11.13B to $11.83B.
- What does europe — consolidated revenues mean?
- This metric represents the total gross revenue generated by the company's operations within the European geographic region. It encompasses sales from scientific instruments, laboratory equipment, diagnostics, and life science services provided to customers located in this territory. This figure serves as a key indicator of the company's market penetration and demand strength in the European life sciences and healthcare sectors.
Ask your AI about Thermo Fisher Scientific's europe — consolidated revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude